Quality signals don’t cross borders the way patients expect them to.
That’s the core finding of a July 2026 study in The Conversation by consumer-decision researchers Kelli Frias of American University and Deidre Popovich of Texas Tech University. They interviewed 71 Americans who sought some of their healthcare in Mexico.
Every person in the study had employer-sponsored health insurance.
Yet with deductible and copay costs so high, they still could not afford routine care, so they sought cheaper care elsewhere.
I’ve been watching this from the operator side for years. The patients Frias and Popovich describe are the same people who contact MedEscape. They’re insured. They’re employed. And they’re confused about what “good” looks like once they step outside the U.S. system.
This post breaks down what the research actually found, where the quality-signal problem gets dangerous, and how to screen a provider abroad without relying on gut instinct.
The quality signals that stop working at the border
The quality signals that stop working at the border
Frias and Popovich found that many familiar indicators changed meaning across healthcare systems.
A crowded waiting room signals poor quality in U.S. facilities but indicates high demand and provider excellence in Mexican clinics.
Long consultations can signal attentive care in one setting and inefficiency in another.
The researchers call this “interpretive labor.” Consumers are forced to learn how quality indicators work differently in each system. Most people don’t realize they’re doing this. They walk into a clinic in Tijuana or Cancun carrying the same mental checklist they’d use in Phoenix, and the checklist doesn’t apply.
I see this constantly. A patient will tell me they picked a clinic because the lobby looked clean and the front desk spoke English. Those are decent hygiene-and-comfort signals. They tell you almost nothing about clinical outcomes, accreditation status, or what happens if something goes wrong.
Why insured Americans are crossing the border
Insured patients are driving this, not the uninsured
Here’s the part that surprises most people: Frias’s research reveals that insured Americans with “good benefits,” including teachers, police officers, and healthcare workers, regularly cross borders despite having U.S. coverage.
The average annual premium for employer-sponsored family coverage hit $26,993 in 2025, according to KFF’s Employer Health Benefits Survey.
That’s a 6% increase over the prior year, outpacing both the 4% increase in workers’ wages and 2.7% inflation. Workers are paying more every year for coverage that still leaves them exposed to high deductibles.
So even with insurance, a dental implant quoted at $3,000 to $6,000 in the U.S. might as well be unaffordable. In Mexico, that same single implant runs about $900 to $1,500.
In Costa Rica, independent 2026 pricing puts implants at $850 to $2,000, with All-on-4 at $9,500 to $12,000 per arch, still 50-70% below U.S. costs.
The math makes the decision obvious. The quality evaluation is the hard part.
Counterfeit drugs and supply chain risks abroad
The counterfeit problem makes signals even harder to read
This isn’t hypothetical. Between November 2025 and May 2026, COFEPRIS, Mexico’s medicine regulator, issued 30 alerts for counterfeit or unapproved products.
Another 12 alerts regarding pharmaceutical theft point to a black market that further endangers the supply chain.
COFEPRIS issued a health alert for counterfeit Ozempic circulating in Mexico, triggered by analysis submitted by Novo Nordisk Mexico itself. When the manufacturer has to flag fakes of its own product, that’s a supply-chain problem that no amount of lobby decor will reveal to a patient.
This is exactly where working with a screened provider network matters. A patient walking into a tourist-facing pharmacy has no way to verify lot numbers on the spot. A coordinated care model can.
See how we screen our providers
What real quality signals look like abroad
What real quality signals look like abroad
If crowded waiting rooms, clean lobbies, and English-speaking staff aren’t reliable, what is?
Accreditation is the most misunderstood concept in medical tourism. Joint Commission International (JCI) is the global gold standard, certifying more than 1,000 hospitals worldwide. But even JCI has limits. Certification is not a guarantee of outcomes, a distinction the CDC explicitly makes.
Here’s what I tell patients to verify before booking anything:
Board certification. Is the provider board-certified in the specific specialty you need? Not a general practitioner performing cosmetic procedures. An actual specialist, trained and certified.
Accreditation status. Don’t believe a website’s logo. Check it directly through JCI’s public directory.
A clear chain of accountability. A clear price can feel reassuring, but it does not tell you whether the provider is properly trained, who is accountable if care goes wrong, or whether follow-up is coordinated.
Documented outcomes. Ask for complication rates. If a clinic won’t share them, that’s your signal.
What care abroad actually costs, done right
The real cost of getting it wrong (and right)
The savings for Americans who do their homework are real, across every category MedEscape operates in:
Dental: Mexican clinics charge $900 to $1,800 per implant versus $3,000 to $6,000 in the U.S.
A single dental implant in Costa Rica runs between $800 and $1,200, compared to $3,000 to $5,000 in the United States.
Fertility: The average cost of IVF in Mexico ranges from $4,500 to $8,000 per cycle, compared to $15,000 to $25,000 typically charged in the United States. Panama Fertility, one of MedEscape’s partner clinics, operates with U.S.-trained reproductive endocrinologists at a fraction of stateside pricing.
Hair restoration: The average hair transplant cost in Mexico ranges from $3,000 to $4,100. In the United States, the same procedure typically costs around $12,500.
Those numbers are only good numbers when the provider behind them is qualified. A $900 implant from a board-certified prosthodontist using Straumann or Nobel Biocare hardware is a different product than a $900 implant from an unlicensed operator using generic components. Same price. Totally different risk.
What MedEscape does differently
Frias and Popovich’s research confirms something I built MedEscape around: patients can’t be expected to decode a foreign healthcare system on their own. Patients are no longer simply choosing between doctors. They are choosing between different healthcare systems, and the signals they trust may not travel as well as they think.
MedEscape exists to close that gap. Every provider in our network in Mexico, Costa Rica, and Panama is board-certified, pre-screened, and accredited. We coordinate the entire process end to end: consultations, travel, treatment, and follow-up care back home.
You don’t have to decode a foreign system’s quality signals yourself. That’s the whole point.
If you’re considering care abroad, start with a free consultation at gomedescape.com/select-your-category/. I’ll make sure you’re matched with the right provider, not just the cheapest one.